Author: Carly Behm

From new devices to new technology, four spine surgeons told Becker's what they're excited about at their practices in 2023.

Stryker, Johnson & Johnson and Zimmer Biomet posted their first quarter financial results for 2023, and data on their orthopedic sales.

Zimmer Biomet's Persona IQ smart knee implant earned CMS' New Technology Add-on Payment, the company's COO Ivan Tornos said in a May 2 earnings call.

Zimmer Biomet President and CEO Bryan Hanson said the company is still eyeing opportunities for mergers and acquisitions.

Alexander Vaccaro, MD, PhD, and Pierce Nunley, MD, are collaborating with Surgalign to support Holo AI insights and the company's other artificial intelligence platforms.

Stryker posted $4.8 billion in first quarter sales, and CEO Kevin Lobo discussed the company's performance and outlooks in a May 1 earnings call.

Roanoke, Va.-based Carilion Clinic named the chair and vice president of its new neurosurgery department, the Cardinal News reported May 2.

Nicholas Theodore, MD, was named as the principal investigator for a post-market trial evaluating Aclarion's Nociscan for diagnosing back pain.

Hunaldo Villalobos, MD, performed the first U.S. case with Captiva Spine's WatchTower spine navigation system, the medtech company said May 2. 

Zimmer Biomet on May 2 posted $1.8 billion in revenue for the frst quarter of 2023.